The global market for Oligonucleotide Therapeutics Drug was valued at US$ 371 million in the year 2024 and is projected to reach a revised size of US$ 555 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Oligonucleotide Therapeutics Drug Market

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Therapeutics Drug.

The Oligonucleotide Therapeutics Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Therapeutics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oligonucleotide Therapeutics Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oligonucleotide Therapeutics Drug Market Report

Report Metric	Details
Report Name	Oligonucleotide Therapeutics Drug Market
Accounted market size in year	US$ 371 million
Forecasted market size in 2031	US$ 555 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antisense Oligonucleotide Aptamer Other
Segment by Application	Neuromuscular Diseases ATTR Hepatic VOD Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Therapeutics Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oligonucleotide Therapeutics Drug Market growing?

Ans: The Oligonucleotide Therapeutics Drug Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Oligonucleotide Therapeutics Drug Market size in 2031?

Ans: The Oligonucleotide Therapeutics Drug Market size in 2031 will be US$ 555 million.

Who are the main players in the Oligonucleotide Therapeutics Drug Market report?

Ans: The main players in the Oligonucleotide Therapeutics Drug Market are Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics

What are the Application segmentation covered in the Oligonucleotide Therapeutics Drug Market report?

Ans: The Applications covered in the Oligonucleotide Therapeutics Drug Market report are Neuromuscular Diseases, ATTR, Hepatic VOD, Other

What are the Type segmentation covered in the Oligonucleotide Therapeutics Drug Market report?

Ans: The Types covered in the Oligonucleotide Therapeutics Drug Market report are Antisense Oligonucleotide, Aptamer, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antisense Oligonucleotide

1.2.3 Aptamer

1.2.4 Other

1.3 Market by Application

1.3.1 Global Oligonucleotide Therapeutics Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neuromuscular Diseases

1.3.3 ATTR

1.3.4 Hepatic VOD

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oligonucleotide Therapeutics Drug Market Perspective (2020-2031)

2.2 Global Oligonucleotide Therapeutics Drug Growth Trends by Region

2.2.1 Global Oligonucleotide Therapeutics Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oligonucleotide Therapeutics Drug Historic Market Size by Region (2020-2025)

2.2.3 Oligonucleotide Therapeutics Drug Forecasted Market Size by Region (2026-2031)

2.3 Oligonucleotide Therapeutics Drug Market Dynamics

2.3.1 Oligonucleotide Therapeutics Drug Industry Trends

2.3.2 Oligonucleotide Therapeutics Drug Market Drivers

2.3.3 Oligonucleotide Therapeutics Drug Market Challenges

2.3.4 Oligonucleotide Therapeutics Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oligonucleotide Therapeutics Drug Players by Revenue

3.1.1 Global Top Oligonucleotide Therapeutics Drug Players by Revenue (2020-2025)

3.1.2 Global Oligonucleotide Therapeutics Drug Revenue Market Share by Players (2020-2025)

3.2 Global Oligonucleotide Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oligonucleotide Therapeutics Drug Revenue

3.4 Global Oligonucleotide Therapeutics Drug Market Concentration Ratio

3.4.1 Global Oligonucleotide Therapeutics Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapeutics Drug Revenue in 2024

3.5 Global Key Players of Oligonucleotide Therapeutics Drug Head office and Area Served

3.6 Global Key Players of Oligonucleotide Therapeutics Drug, Product and Application

3.7 Global Key Players of Oligonucleotide Therapeutics Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oligonucleotide Therapeutics Drug Breakdown Data by Type

4.1 Global Oligonucleotide Therapeutics Drug Historic Market Size by Type (2020-2025)

4.2 Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Type (2026-2031)

5 Oligonucleotide Therapeutics Drug Breakdown Data by Application

5.1 Global Oligonucleotide Therapeutics Drug Historic Market Size by Application (2020-2025)

5.2 Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oligonucleotide Therapeutics Drug Market Size (2020-2031)

6.2 North America Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025)

6.4 North America Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oligonucleotide Therapeutics Drug Market Size (2020-2031)

7.2 Europe Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025)

7.4 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oligonucleotide Therapeutics Drug Market Size (2020-2031)

8.2 Asia-Pacific Oligonucleotide Therapeutics Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oligonucleotide Therapeutics Drug Market Size (2020-2031)

9.2 Latin America Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025)

9.4 Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size (2020-2031)

10.2 Middle East & Africa Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Oligonucleotide Therapeutics Drug Introduction

11.1.4 Biogen Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.1.5 Biogen Recent Development

11.2 Sarepta Therapeutics

11.2.1 Sarepta Therapeutics Company Details

11.2.2 Sarepta Therapeutics Business Overview

11.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Introduction

11.2.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.2.5 Sarepta Therapeutics Recent Development

11.3 Jazz Pharmaceuticals

11.3.1 Jazz Pharmaceuticals Company Details

11.3.2 Jazz Pharmaceuticals Business Overview

11.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Introduction

11.3.4 Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.3.5 Jazz Pharmaceuticals Recent Development

11.4 Bausch & Lomb

11.4.1 Bausch & Lomb Company Details

11.4.2 Bausch & Lomb Business Overview

11.4.3 Bausch & Lomb Oligonucleotide Therapeutics Drug Introduction

11.4.4 Bausch & Lomb Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.4.5 Bausch & Lomb Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Details

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Dynavax Technologies

11.6.1 Dynavax Technologies Company Details

11.6.2 Dynavax Technologies Business Overview

11.6.3 Dynavax Technologies Oligonucleotide Therapeutics Drug Introduction

11.6.4 Dynavax Technologies Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.6.5 Dynavax Technologies Recent Development

11.7 Kastle therapeutics

11.7.1 Kastle therapeutics Company Details

11.7.2 Kastle therapeutics Business Overview

11.7.3 Kastle therapeutics Oligonucleotide Therapeutics Drug Introduction

11.7.4 Kastle therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.7.5 Kastle therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Details

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Drug Introduction

11.8.4 Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025)

11.8.5 Akcea Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alnylam Pharmaceuticals

Dynavax Technologies

Kastle therapeutics

Akcea Therapeutics

List of Tables

Table 1. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antisense Oligonucleotide

Table 3. Key Players of Aptamer

Table 4. Key Players of Other

Table 5. Global Oligonucleotide Therapeutics Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oligonucleotide Therapeutics Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oligonucleotide Therapeutics Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oligonucleotide Therapeutics Drug Market Share by Region (2020-2025)

Table 9. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oligonucleotide Therapeutics Drug Market Share by Region (2026-2031)

Table 11. Oligonucleotide Therapeutics Drug Market Trends

Table 12. Oligonucleotide Therapeutics Drug Market Drivers

Table 13. Oligonucleotide Therapeutics Drug Market Challenges

Table 14. Oligonucleotide Therapeutics Drug Market Restraints

Table 15. Global Oligonucleotide Therapeutics Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oligonucleotide Therapeutics Drug Market Share by Players (2020-2025)

Table 17. Global Top Oligonucleotide Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics Drug as of 2024)

Table 18. Ranking of Global Top Oligonucleotide Therapeutics Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapeutics Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oligonucleotide Therapeutics Drug, Headquarters and Area Served

Table 21. Global Key Players of Oligonucleotide Therapeutics Drug, Product and Application

Table 22. Global Key Players of Oligonucleotide Therapeutics Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oligonucleotide Therapeutics Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Oligonucleotide Therapeutics Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Biogen Company Details

Table 48. Biogen Business Overview

Table 49. Biogen Oligonucleotide Therapeutics Drug Product

Table 50. Biogen Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 51. Biogen Recent Development

Table 52. Sarepta Therapeutics Company Details

Table 53. Sarepta Therapeutics Business Overview

Table 54. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product

Table 55. Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 56. Sarepta Therapeutics Recent Development

Table 57. Jazz Pharmaceuticals Company Details

Table 58. Jazz Pharmaceuticals Business Overview

Table 59. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product

Table 60. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 61. Jazz Pharmaceuticals Recent Development

Table 62. Bausch & Lomb Company Details

Table 63. Bausch & Lomb Business Overview

Table 64. Bausch & Lomb Oligonucleotide Therapeutics Drug Product

Table 65. Bausch & Lomb Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 66. Bausch & Lomb Recent Development

Table 67. Alnylam Pharmaceuticals Company Details

Table 68. Alnylam Pharmaceuticals Business Overview

Table 69. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product

Table 70. Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 71. Alnylam Pharmaceuticals Recent Development

Table 72. Dynavax Technologies Company Details

Table 73. Dynavax Technologies Business Overview

Table 74. Dynavax Technologies Oligonucleotide Therapeutics Drug Product

Table 75. Dynavax Technologies Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 76. Dynavax Technologies Recent Development

Table 77. Kastle therapeutics Company Details

Table 78. Kastle therapeutics Business Overview

Table 79. Kastle therapeutics Oligonucleotide Therapeutics Drug Product

Table 80. Kastle therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 81. Kastle therapeutics Recent Development

Table 82. Akcea Therapeutics Company Details

Table 83. Akcea Therapeutics Business Overview

Table 84. Akcea Therapeutics Oligonucleotide Therapeutics Drug Product

Table 85. Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 86. Akcea Therapeutics Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Oligonucleotide Therapeutics Drug Picture

Figure 2. Global Oligonucleotide Therapeutics Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oligonucleotide Therapeutics Drug Market Share by Type: 2024 VS 2031

Figure 4. Antisense Oligonucleotide Features

Figure 5. Aptamer Features

Figure 6. Other Features

Figure 7. Global Oligonucleotide Therapeutics Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oligonucleotide Therapeutics Drug Market Share by Application: 2024 VS 2031

Figure 9. Neuromuscular Diseases Case Studies

Figure 10. ATTR Case Studies

Figure 11. Hepatic VOD Case Studies

Figure 12. Other Case Studies

Figure 13. Oligonucleotide Therapeutics Drug Report Years Considered

Figure 14. Global Oligonucleotide Therapeutics Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Oligonucleotide Therapeutics Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oligonucleotide Therapeutics Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Oligonucleotide Therapeutics Drug Market Share by Players in 2024

Figure 18. Global Top Oligonucleotide Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Oligonucleotide Therapeutics Drug Revenue in 2024

Figure 20. North America Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Oligonucleotide Therapeutics Drug Market Share by Country (2020-2031)

Figure 22. United States Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oligonucleotide Therapeutics Drug Market Share by Country (2020-2031)

Figure 26. Germany Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oligonucleotide Therapeutics Drug Market Share by Region (2020-2031)

Figure 34. China Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oligonucleotide Therapeutics Drug Market Share by Country (2020-2031)

Figure 42. Mexico Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oligonucleotide Therapeutics Drug Market Share by Country (2020-2031)

Figure 46. Turkey Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Oligonucleotide Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Biogen Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 50. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 51. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 52. Bausch & Lomb Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 53. Alnylam Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 54. Dynavax Technologies Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 55. Kastle therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 56. Akcea Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

Oligonucleotide based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide and Oligonucleotide Drugs Market Research Report 2024

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global Oligonucleotide based Therapy Medicinal Product Market Research Report 2024

Global Oligonucleotide Therapy based Drug Market Research Report 2024

Global Nucleotide based Therapeutics Market Research Report 2024

Global Oligonucleotide Drug Delivery Market Research Report 2024

Global Oligonucleotide Drug Carriers Market Research Report 2024

Global Oligonucleotide Market Research Report 2025

Global Nucleic Acid Drugs Market Research Report 2025

Small Molecule Nucleic Acid Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Medicine Market Research Report 2025

Global Oligonucleotides Market Insights Forecast to 2030

Global Nucleic Acid based Therapy Market Research Report 2024

Global Nucleic Acid Therapeutic Market Research Report 2024

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19T19555

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30T17927

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18L19449

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Metabolite Chemistry Reagents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-14103

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions